Eric Winquist, Mark Vincent, Walter Stadler. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Abducens Nerve Diseases/chemically inducedAcute DiseaseAgedAntineoplastic Agents/administration & dosageAntineoplastic Agents/adverse effectsCarcinoma, Transitional Cell/drug therapyCarcinoma, Transitional Cell/secondaryHumansKidney Neoplasms/drug therapyKidney Neoplasms/pathologyLarynx/drug effectsLiver Neoplasms/drug therapyLiver Neoplasms/secondaryMaleOrganoplatinum Compounds/administration & dosageOrganoplatinum Compounds/adverse effectsOxaliplatinParalysis/chemically inducedParesthesia/chemically inducedPharynx/drug effectsTime Factors
Substances： See more » Antineoplastic AgentsOrganoplatinum CompoundsOxaliplatin
Year: 2003 PMID： 12644545 DOI： 10.1093/jnci/95.6.488
Source DB: PubMed Journal: J Natl Cancer Inst ISSN： 0027-8874 Impact factor: 13.506